- Home
- PRCT vs ARWR Comparison
PRCT vs ARWR Comparison
Compare PRCT & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRCT
- ARWR
- Stock Information
- Founded
- PRCT 2009
- ARWR 2003
- Country
- PRCT United States
- ARWR United States
- Employees
- PRCT N/A
- ARWR N/A
- Industry
- PRCT Medical Specialities
- ARWR Biotechnology: Pharmaceutical Preparations
- Sector
- PRCT Health Care
- ARWR Health Care
- Exchange
- PRCT Nasdaq
- ARWR Nasdaq
- Market Cap
- PRCT 2.1B
- ARWR 2.5B
- IPO Year
- PRCT 2021
- ARWR 1993
- Fundamental
- Price
- PRCT $34.63
- ARWR $36.76
- Analyst Decision
- PRCT Buy
- ARWR Strong Buy
- Analyst Count
- PRCT 8
- ARWR 8
- Target Price
- PRCT $70.00
- ARWR $47.75
- AVG Volume (30 Days)
- PRCT 1.0M
- ARWR 2.4M
- Earning Date
- PRCT 10-27-2025
- ARWR 11-25-2025
- Dividend Yield
- PRCT N/A
- ARWR N/A
- EPS Growth
- PRCT N/A
- ARWR N/A
- EPS
- PRCT N/A
- ARWR N/A
- Revenue
- PRCT $274,950,000.00
- ARWR $572,976,000.00
- Revenue This Year
- PRCT $48.38
- ARWR $21,619.52
- Revenue Next Year
- PRCT $30.87
- ARWR N/A
- P/E Ratio
- PRCT N/A
- ARWR N/A
- Revenue Growth
- PRCT 55.71
- ARWR 2816.20
- 52 Week Low
- PRCT $34.01
- ARWR $9.57
- 52 Week High
- PRCT $103.81
- ARWR $39.42
- Technical
- Relative Strength Index (RSI)
- PRCT 36.50
- ARWR 74.75
- Support Level
- PRCT $34.01
- ARWR $31.46
- Resistance Level
- PRCT $36.48
- ARWR $39.38
- Average True Range (ATR)
- PRCT 1.58
- ARWR 1.47
- MACD
- PRCT 0.00
- ARWR 0.13
- Stochastic Oscillator
- PRCT 9.20
- ARWR 73.21
About PRCT PROCEPT BioRobotics Corporation
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, which are image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.